Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ONCE
Delisted

Spark Therapeutics Stock Price (Quote)

$113.57
+0 (+0%)
At Close: Jan 24, 2020

Range Low Price High Price Comment
30 days $113.57 $113.57 Friday, 24th Jan 2020 ONCE stock ended at $113.57. During the day the stock fluctuated 0% from a day low at $113.57 to a day high of $113.57.
90 days $108.00 $113.90
52 weeks $40.64 $114.20

Historical Spark Therapeutics prices

Date Open High Low Close Volume
Jul 26, 2019 $97.40 $98.48 $96.85 $98.08 286 435
Jul 25, 2019 $97.23 $97.93 $96.48 $96.85 299 031
Jul 24, 2019 $96.06 $97.40 $95.32 $96.82 534 009
Jul 23, 2019 $96.85 $96.89 $95.76 $96.12 340 743
Jul 22, 2019 $96.96 $97.66 $96.09 $96.41 312 723
Jul 19, 2019 $97.90 $98.99 $96.63 $96.85 287 544
Jul 18, 2019 $97.02 $98.29 $96.72 $98.18 241 569
Jul 17, 2019 $97.60 $97.70 $95.96 $97.02 453 253
Jul 16, 2019 $98.16 $98.62 $97.08 $97.67 447 273
Jul 15, 2019 $98.40 $99.60 $97.45 $98.00 378 059
Jul 12, 2019 $98.58 $99.16 $97.29 $98.05 343 094
Jul 11, 2019 $99.56 $100.24 $96.32 $98.23 555 075
Jul 10, 2019 $100.38 $100.93 $98.55 $99.16 361 274
Jul 09, 2019 $101.38 $102.03 $100.05 $100.25 443 859
Jul 08, 2019 $102.00 $103.03 $100.74 $101.18 987 461
Jul 05, 2019 $102.54 $103.71 $102.54 $103.07 288 997
Jul 03, 2019 $102.43 $102.71 $101.22 $102.48 215 082
Jul 02, 2019 $102.59 $102.94 $101.52 $102.08 335 254
Jul 01, 2019 $103.02 $103.71 $100.67 $102.50 353 898
Jun 28, 2019 $102.43 $102.57 $100.95 $102.38 835 165
Jun 27, 2019 $102.34 $102.99 $101.52 $102.18 257 221
Jun 26, 2019 $101.29 $102.36 $100.81 $102.31 260 309
Jun 25, 2019 $102.44 $102.44 $100.13 $100.79 757 222
Jun 24, 2019 $103.27 $104.08 $101.25 $101.91 1 490 751
Jun 21, 2019 $102.52 $105.48 $102.52 $105.07 1 132 950
Click to get the best stock tips daily for free!

About Spark Therapeutics

Spark Therapeutics Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. The company develops SPK-RPE65, which is in Phase III clinical trial for the treatment of genetic blinding conditions called inherited retinal diseases caused by non sex-linked, autosomal recessive, or mutations in the RPE65 gene; and SPK-CHM that is in Phase I/II clinical trial for the treatment of choroideremia... ONCE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT